TRUALT BIOENERGY
|
|
| BOM : 544545     NSE : TRUALT     | |
| LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : Average [>25% and <50%] |
Jul 15,2026 |
|
Price(EOD): ₹ 427.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Breweries & Distilleries |
| MCap: ₹ 3,670.95 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| TRUALT BIOENERGY | -4.2% | -13.3% | NA |
| UNITED SPIRITS | -0.5% | 8% | 1.6% |
| RADICO KHAITAN | 0.1% | 14.1% | 53.7% |
| UNITED BREWERIES | 2.2% | 0.8% | -31.8% |
| ALLIED BLENDERS AND DISTILLERS | -6.9% | -1% | 40.8% |
| TILAKNAGAR INDUSTRIES | -1.1% | 1.3% | 27.8% |
| INDIA GLYCOLS | 8.8% | 16.3% | 9.5% |
| PICCADILY AGRO INDUSTRIES | 12.1% | 26.9% | 20.7% |
| GLOBUS SPIRITS | 4% | 11.3% | -0.7% |
FUNDAMENTAL ANALYSIS OF TRUALT BIOENERGY
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF TRUALT BIOENERGY
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
37.85
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 96.92 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 4.77
P/B Calculated based on Book Value of Rs 769.00 Cr
[Latest Year - Mar2025 - Consolidated Results ] 2.12
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,727.51 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
323% 319% - |
SHARE PRICE MOMENTUM OF TRUALT BIOENERGY
TRUALT BIOENERGY vs SENSEX
DEBT OF TRUALT BIOENERGY
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
2 6.16 4.78 4.31 |
2.02 6.37 - 2.8 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF TRUALT BIOENERGY
| Pledged Promoter Shares |
36.85 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF TRUALT BIOENERGY
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-16.5% -11.37% -6.67% -11.91% |
-34.34% -22.74% -24.52% -45.43% |
| QtrlyTrend |
-8 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
TRUALT BIOENERGY related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE IPO | 2.6% | 7.1% | 16.4% |
| BSE FAST MOVING CONSUMER GOODS | -0.8% | -0.4% | -11.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY IPO INDEX | 2.6% | 7.2% | 13.4% |
You may also like the below Video Courses
FAQ about TRUALT BIOENERGY
Is TRUALT BIOENERGY good for long term investment?
As on Jul 15,2026, the Fundamentals of TRUALT BIOENERGY look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of TRUALT BIOENERGY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is TRUALT BIOENERGY UnderValued or OverValued?
As on Jul 15,2026, TRUALT BIOENERGY is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of TRUALT BIOENERGY ?
As on Jul 15,2026, the Intrinsic Value of TRUALT BIOENERGY is Rs. 101.60 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 101.12
Fair Value [Median EV / Sales Model] : Rs. 102.07
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of TRUALT BIOENERGY : Rs. 101.60
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.